22
Clinical Research use only, Not for use in Diagnostics Procedure Kevin He and Marta Kozak Clinical Research Applications Group Thermo Fisher Scientific San Jose, CA Quantitation of Testosterone Using Q Exactive Mass Spectrometer - Comparison of APCI, APPI and HESI Sources

Testosteron LC MS MS APPI

Embed Size (px)

DESCRIPTION

detremine testosterone by LC/MS/MS from human body.

Citation preview

Clinical Research use only, Not for use in Diagnostics Procedure

Kevin He and Marta Kozak

Clinical Research Applications Group

Thermo Fisher Scientific San Jose, CA

Quantitation of Testosterone Using

Q Exactive Mass Spectrometer - Comparison of

APCI, APPI and HESI Sources

2 Clinical Research use only, Not for use in Diagnostics Procedure

Instrumentation

• LC system: Accela 600 pump

• Q Exactive equipped with APCI + Ion Max TM source

3 Clinical Research use only, Not for use in Diagnostics Procedure

Instrumentation

• LC system: Accela 600 pump

• Autosampler: Thermal Pal

• Q ExactiveTM mass spectrometer equipped with APCI (or HESI, APPI) + Ion Max TM source

4 Clinical Research use only, Not for use in Diagnostics Procedure

Calibration Curve Standards

• Calibration standards were prepared in 50% MeOH/water.

• Injection volume: 50 µL

Sample Testosterone

(pg/mL)

Testosterone-3-C13

(pg/mL)

Blank+IS 0 100

Cal1 5 100

Cal2 10 100

Cal3 20 100

Cal4 50 100

Cal5 100 100

Cal6 250 100

Cal7 500 100

5 Clinical Research use only, Not for use in Diagnostics Procedure

LC Method

• Analytical Column: Hypersil GOLD aQ 100 x 3.0 mm, 5 µm particle size

• Mobile Phase

� A: 5% MeOH in DI water

� B: MeOH

� C: ACN/IPA/Acetone: 45/45/10

• Autosampler wash solution #1: Water

• Autosampler wash solution #2: MeOH

• LC Gradient

Time(min) %A %B %C Flow (µµµµL/min)

0 95 5 0 600

0.1 60 40 0 600

0.5 60 40 0 600

3.5 5 95 0 600

4.5 5 95 0 600

4.51 0 0 100 800

5 0 0 100 800

5.1 95 5 0 800

6.5 95 5 0 800

6 Clinical Research use only, Not for use in Diagnostics Procedure

MS Method: APCI source parameters

Q Exactive systemIonization APCI, positive, Ion Max™ source

Vaporizer temperature (ºC) 350

Capillary temperature (ºC) 320

Discharge current (µA) 5.0

Sheath gas (units) 10

Aux gas (units) 20

S-lens Level 60

Probe position between B and C

Divert valve: initial position to waste, at 1.5 min position to detector and at 5.5 min position switched back to waste

7 Clinical Research use only, Not for use in Diagnostics Procedure

MS Method: APPI source parameters

Q Exactive systemIonization APPI, positive, Ion Max™ source

Vaporizer temperature (ºC) 350

Capillary temperature (ºC) 320

Spray voltage (V) 4000

Sheath gas (units) 10

Aux gas (units) 20

S-lens Level 60

Probe position between B and C

Divert valve: initial position to waste, at 1.5 min position to detector and at 5.5 min position switched back to waste

We did not test the APPI method with “teed-in” dopant infusion, but it seemed that testosterone could ionize sufficiently well without it under the current conditions.

8 Clinical Research use only, Not for use in Diagnostics Procedure

MS Method: HESI source parameters

Q Exactive systemIonization HESI-II, positive, Ion Max™ source

Vaporizer temperature (ºC) 350

Capillary temperature (ºC) 320

Spray voltage (V) 4000

Sheath gas (units) 10

Aux gas (units) 20

S-lens Level 60

Probe position between B and C

Divert valve: initial position to waste, at 1.5 min position to detector and at 5.5 min position switched back to waste

9 Clinical Research use only, Not for use in Diagnostics Procedure

MS acquisition method

• Acquisition mode: HCD fragmentation with collision energy set to 40%

NCE

• Precursor isolation width: 2 mu

• Resolution: 35K @ 200 m/z

• AGC Target: 1e5

• Max injection time: 120ms

• Inclusion list:

• Testosterone: 289.2 (fragment ions - 97.0648, 109.0648)

• Testosterone-3-C13: 292.2 (fragment ions -100.0748, 112.0748)

289.2 � 97.0648 289.2 � 109.0648 m/z

10 Clinical Research use only, Not for use in Diagnostics Procedure

Acquisition method parameters: screen capture

11 Clinical Research use only, Not for use in Diagnostics Procedure

LC Gradient: screen capture

12 Clinical Research use only, Not for use in Diagnostics Procedure

IS in 50% MeOH/H2O – 100 pg/mL

2.00 - 6.00

2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5

Time (min)

0

10

20

30

40

50

60

70

80

90

100

0

10

20

30

40

50

60

70

80

90

100

0

10

20

30

40

50

60

70

80

90

100AA: 149119

AA: 320849

AA: 486625

RT: 2.00 - 6.00

2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0

Time (min)

0

10

20

30

40

50

60

70

80

90

100

0

10

20

30

40

50

60

70

80

90

100

Re

lative

Ab

un

da

nce

0

10

20

30

40

50

60

70

80

90

100AA: 180054

AA: 389064

AA: 574722

292.2 � 100.0749 292.2 � 112.0749 m/z

HESI

APPI

APCI

13 Clinical Research use only, Not for use in Diagnostics Procedure

IS signals using different sources (n=6)

0

100000

200000

300000

400000

500000

600000

HESI APPI APCI

100.0748 m/z

112.0748 m/z

14 Clinical Research use only, Not for use in Diagnostics Procedure

Testosterone 5 pg/mL

289.2 � 97.0648

HESI

APPI

APCI

2.00 - 6.00 SM: 3B

2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0

Time (min)

0

10

20

30

40

50

60

70

80

90

100

0

10

20

30

40

50

60

70

80

90

100

0

10

20

30

40

50

60

70

80

90

100

MA: 4785

RT: 2.00 - 6.00 SM: 3B

2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0

Time (min)

0

10

20

30

40

50

60

70

80

90

100

0

10

20

30

40

50

60

70

80

90

100

Re

lative

Ab

un

da

nce

0

10

20

30

40

50

60

70

80

90

100

MA: 3720

289.2 � 109.0648 m/z

15 Clinical Research use only, Not for use in Diagnostics Procedure

Testosterone 10 pg/mL

289.2 � 97.0648

HESI

APPI

APCI

2.00 - 6.00 SM: 3B

2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0

Time (min)

0

10

20

30

40

50

60

70

80

90

100

0

10

20

30

40

50

60

70

80

90

100

0

10

20

30

40

50

60

70

80

90

100

AA: 3024

AA: 7995

RT: 2.00 - 6.00 SM: 3B

2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0

Time (min)

0

10

20

30

40

50

60

70

80

90

100

0

10

20

30

40

50

60

70

80

90

100

Re

lative

Ab

un

da

nce

0

10

20

30

40

50

60

70

80

90

100

AA: 5515

AA: 13408

289.2 � 109.0648 m/z

16 Clinical Research use only, Not for use in Diagnostics Procedure

Testosterone 20 pg/mL

289.2 � 97.0648

HESI

APPI

APCI

2.00 - 6.00 SM: 3B

2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0

Time (min)

0

10

20

30

40

50

60

70

80

90

100

0

10

20

30

40

50

60

70

80

90

100

0

10

20

30

40

50

60

70

80

90

100

MA: 10810

MA: 32233

RT: 2.00 - 6.00 SM: 3B

2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0

Time (min)

0

10

20

30

40

50

60

70

80

90

100

0

10

20

30

40

50

60

70

80

90

100

Re

lative

Ab

un

da

nce

0

10

20

30

40

50

60

70

80

90

100

AA: 14275

MA: 22946

289.2 � 109.0648 m/z

17 Clinical Research use only, Not for use in Diagnostics Procedure

Testosterone 50 pg/mL

289.2 � 97.0648

HESI

APPI

APCI

2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0

Time (min)

0

10

20

30

40

50

60

70

80

90

100

0

10

20

30

40

50

60

70

80

90

100

0

10

20

30

40

50

60

70

80

90

100

MA: 10860

AA: 38892

AA: 97531

2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0

Time (min)

0

10

20

30

40

50

60

70

80

90

100

0

10

20

30

40

50

60

70

80

90

100

Re

lative

Ab

un

da

nce

0

10

20

30

40

50

60

70

80

90

100

MA: 17425

MA: 45872

MA: 82318

289.2 � 109.0648 m/z

18 Clinical Research use only, Not for use in Diagnostics Procedure

Testosterone 100 pg/mL

289.2 � 97.0648 289.2 � 109.0648 m/z

HESI

APPI

APCI

2.00 - 6.00 SM: 5B

2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0

Time (min)

0

10

20

30

40

50

60

70

80

90

100

0

10

20

30

40

50

60

70

80

90

100

0

10

20

30

40

50

60

70

80

90

100MA: 25313

AA: 73646

AA: 185688

RT: 2.00 - 6.00 SM: 5B

2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0

Time (min)

0

10

20

30

40

50

60

70

80

90

100

0

10

20

30

40

50

60

70

80

90

100

Re

lative

Ab

un

da

nce

0

10

20

30

40

50

60

70

80

90

100MA: 36196

MA: 92064

MA: 204055

19 Clinical Research use only, Not for use in Diagnostics Procedure

Testosterone 250 pg/mL

289.2 � 97.0648

HESI

APPI

APCI

2.00 - 6.00 SM: 5B

2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0

Time (min)

0

10

20

30

40

50

60

70

80

90

100

0

10

20

30

40

50

60

70

80

90

100

0

10

20

30

40

50

60

70

80

90

100AA: 151683

AA: 211707

AA: 490293

RT: 2.00 - 6.00 SM: 5B

2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0

Time (min)

0

10

20

30

40

50

60

70

80

90

100

0

10

20

30

40

50

60

70

80

90

100

Re

lative

Ab

un

da

nce

0

10

20

30

40

50

60

70

80

90

100AA: 173866

AA: 250155

AA: 604848

289.2 � 109.0648 m/z

20 Clinical Research use only, Not for use in Diagnostics Procedure

Testosterone Calibration Curve (APCI, 97.0648 m/z)

Concentration (pg/mL)

testo97Y = -0.00821055+0.00437969*X R^2 = 0.9949 W: 1/X

0 20 40 60 80 100 120 140 160 180 200 220 240 260

0.0

0.1

0.2

0.3

0.4

0.5

0.6

0.7

0.8

0.9

1.0

1.1

1.2

Are

a R

atio

Specified

(pg/mL)

Diffe.

(%)

5 5.76

10 10.35

20 -7.95

50 -3.07

100 -9.68

250 4.59

21 Clinical Research use only, Not for use in Diagnostics Procedure

Testosterone Calibration Curve (APPI, 97.0648 m/z)

Concentration (pg/mL)

Specified

(pg/mL)

Diffe.

(%)

5 3.69

10 -7.64

20 -2.58

50 4.19

100 4.57

250 -2.23

testo97Y = -0.0141408+0.00371641*X R^2 = 0.9985 W: 1/X

0 20 40 60 80 100 120 140 160 180 200 220 240 260

0.00

0.05

0.10

0.15

0.20

0.25

0.30

0.35

0.40

0.45

0.50

0.55

0.60

0.65

0.70

0.75

0.80

0.85

0.90

0.95

1.00A

rea R

atio

22 Clinical Research use only, Not for use in Diagnostics Procedure

Conclusion

• We have tested the detection of testosterone with LC-MS/MS using three ionization techniques: HESI, APPI and APCI.

• With most of the source parameters consistent, the order of signal intensity of ionized

testosterone is (from highest to lowest): APCI, APPI and HESI.

• We can detect 5 pg/mL testosterone in neat solutions with both APPI and APCI, but not

HESI (>50 pg/mL), under the current conditions.

• While APPI ranked in the middle in terms of signal intensity, the background signals were

lowest. And we observed excellent calibration curve.

• Regardless of the ionization technique, we observe the consistent ion ratio between the

two major fragment ions.

• Due to multiple reasons, we did not add dopant for APPI, which might further improve the

performance.

• Concentrations of testosterone in this presentation were the straight-up values in the

glass inserts. For real samples, we will have ≥2 concentration factor and it will improve

LLOQ by ~ 2 fold.